Filtered By:
Procedure: Heart Transplant
This page shows you your search results in order of date. This is page number 17.
Order by Relevance | Date
Total 1298 results found since Jan 2013.
Prognostic Value of Pressure-Volume Measures in Hemocompatibility-Related Clinical Adverse Events
Continuous-flow left ventricular assist device (cf-LVADs) can lead to hemocompatibility-related clinical adverse events (HRAEs) which are largely determined by mechanisms that underpin the pump-patient interaction. We assessed the association of pressure-volume (PV) measures [stroke work (SW)& pump arterial elastance (EA)] with incidence of HRAEs.
Source: The Journal of Heart and Lung Transplantation - April 1, 2022 Category: Transplant Surgery Authors: A. Gunawan, D. Robson, A. Ramanayake, R.J. Krishnaswamy, K. Kearney, K. Muthiah, P. Jain, A. Adji, C.S. Hayward Tags: (220) Source Type: research
Postoperative Atrial Fibrillation in Lung Transplant Recipients with and without Concomitant Modified Maze
Atrial fibrillation is common following lung transplantation and may contribute to increased risk of stroke. The goal of this study was to characterize the incidence of atrial fibrillation in lung transplant recipients with and without a concomitant modified Maze procedure.
Source: The Journal of Heart and Lung Transplantation - April 1, 2022 Category: Transplant Surgery Authors: Y. Xia, S. Patel, S. Lee, R. Villamater, R. Biniwale, A. Ardehali Tags: (633) Source Type: research
Stroke Risk in the Contemporary Era of Left Ventricular Assist Device Support
The HeartMate 3 left ventricular assist device (LVAD) has lower stroke rates compared to the HeartMate 2 in a clinical trial setting. Here we report real world stroke rates in patients implanted with HeartMate 2 and HeartMate 3 LVADs.
Source: The Journal of Heart and Lung Transplantation - April 1, 2022 Category: Transplant Surgery Authors: J. Leonard, A. Shaaban, A.C. Agdamag, Z. Jedeon, R. John, F. Kamdar, V. Maharaj, R. Cogswell Tags: (119) Source Type: research
Protein Biomarkers Predict Risk of Gastrointestinal Bleeding in Left Ventricular Assist Device Patients
This study aims to assess the validity of these biomarkers in predicting the incidence of stroke or GIB in LVAD recipients.
Source: The Journal of Heart and Lung Transplantation - April 1, 2022 Category: Transplant Surgery Authors: K. Cavallo, M. Kanwar, G. Diao, S.S. Sinha, R. Singh, D. Tang, I. Isseh, J. Brocious, P. Bagchi, D. Crandall, D.J. Farrar, S. Murali, J. Walenga, J. Lindenfeld, C. deFilippi, P. Shah Tags: (115) Source Type: research
Sex-Based Differences in Clinical Outcomes of Stroke Related to LVAD
Sex-based differences among patients with left ventricular assist devices (LVAD) having stroke are uncertain. We aimed to compare demographic and clinical characteristics, inpatient outcomes, and measures of health care utilization among men and women who had stroke while undergoing LVAD implantation.
Source: The Journal of Heart and Lung Transplantation - April 1, 2022 Category: Transplant Surgery Authors: M. Kassi, A.M. Minhas, S.U. Khan, A. Shah, R. Yousafzai, A. Guha, A. Bhimaraj Tags: (358) Source Type: research
Association of Outflow Cannula Angulation with Adverse Neurological Events in Patients with CF-LVAD
Adverse neurological outcomes are the Achilles heel of the current day LVAD technology and are associated with worse survival. Our previous data suggests that outflow cannula (OFC) angles measured using cardiac CT may correlate with stroke in continuous-flow HeartMate II patients. Therefore, the aim of our study was to assess the relationship of inflow cannula (IFC) and outflow cannula (OFC) position with neurological outcomes centrifugal flow pumps (HM3 and HVAD).
Source: The Journal of Heart and Lung Transplantation - April 1, 2022 Category: Transplant Surgery Authors: M. Kassi, S. Ingram, T. Garg, M. Chavez, M. Khan, A. Shah, R. Thaker, E. Graviss, N. Duc, A. Guha, E. Suarez, A. Bhimaraj Tags: (53) Source Type: research
Reservoir Pressure Analysis in Group 2 Pulmonary Hypertension
In this study we aim to describe Pres in Group 2 isolated post-capillary (IPC) and combined pre and post-capillary (CPC) pulmonary hypertension (PH).
Source: The Journal of Heart and Lung Transplantation - April 1, 2022 Category: Transplant Surgery Authors: I. Yim, K. Parker, S. Lim Tags: (307) Source Type: research
Transapical Ventricular Remodeling for Hypertrophic Cardiomyopathy with Systolic Cavity Obliteration
CONCLUSIONS: Transapical myectomy to enlarge LV cavity volume can be performed safely with good early survival and functional results. This procedure is an important alternative to cardiac transplantation for HCM patients with systolic cavity obliteration and progressive heart failure.PMID:35339438 | DOI:10.1016/j.athoracsur.2022.02.073
Source: The Annals of Thoracic Surgery - March 27, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Daokun Sun Hartzell V Schaff Rick A Nishimura Jeffrey B Geske Joseph A Dearani Steve R Ommen Source Type: research
Phenylephrine-Induced Cardiovascular Changes in the Anesthetized Mouse: An Integrated Assessment of in vivo Hemodynamics Under Conditions of Controlled Heart Rate
ConclusionIn conclusion, this in vivo murine model is capable of distinguishing between changes in peripheral vascular and cardiac functions. This study underlines the primary effect of phenylephrine on vascular function with secondary changes to cardiac function. Hence, this in vivo model is useful for the integrated assessment of the cardiovascular system.
Source: Frontiers in Physiology - February 17, 2022 Category: Physiology Source Type: research
Bacteriophage Therapy and the Biofilm: An Old Solution for a Persistent and Desperate Problem?
With the adoption of use of continuous-flow pumps with centrifugal design and complete magnetic levitation (i.e., HeartMate 3, Abbott, Chicago, IL), outcomes following durable left ventricular assist device (LVAD) have continuously improved over the last five years (1). Improved hemocompatibility associated with this device design has translated into a significant reduction in major adverse events, primarily pump thrombosis, stroke, and to a lesser extent, reduction in non-surgical bleeding (1).
Source: The Journal of Heart and Lung Transplantation - February 14, 2022 Category: Transplant Surgery Authors: Pierre-Emmanuel Noly, Francis D. Pagani Tags: Editorial Source Type: research
Hypertrophic Cardiomyopathy: New Concepts and Therapies
Annu Rev Med. 2022 Jan 27;73:363-375. doi: 10.1146/annurev-med-042220-021539.ABSTRACTHypertrophic cardiomyopathy (HCM), a relatively common, globally distributed, and often inherited myocardial disorder, transformed over the last several years into a treatable condition with the emergence of effective management options that alter natural history at all ages. Now available are a matured risk stratification algorithm selecting patients for prophylactic implantable defibrillators that prevent arrhythmic sudden death; low-risk, high-benefit surgical myectomy to reverse progressive heart failure symptoms due to left ventricula...
Source: Annual Review of Medicine - January 27, 2022 Category: General Medicine Authors: Barry J Maron Ethan J Rowin Martin S Maron Source Type: research
